OMXUS Press

The Dealer Doesn't Check ID

A. C. Applebee and L. N. Combe

2026

2,617 words ~10 min read 7 chapters
Read Now

Abstract

Contents

Call it what it is The history is not what you think The safety paradox What Subject L would have got The pharmaceutical monopoly What Subject M wants Sources

Call it what it is

When someone else decides what goes into your body without your consent, there is a word for that. We use it in every other context. When it is food, we call it poisoning. When it is medicine, we call it malpractice. When it is physical, we call it assault. When it is sexual, we call it rape.

When the state decides what you are permitted to put in your own body — when it criminalises your consciousness, when it sends armed men to your house because of what you chose to ingest, when it puts you in a cage for a decision that harmed nobody but yourself — what do you call that?

The word matters. Because the moment you name it, the moral framework inverts. The person in the cage is not the criminal. The person who put them there is.

Drug laws do not protect bodily autonomy. They violate it. They take the most fundamental right a person has — sovereignty over their own body, the right to decide what enters it — and hand that right to politicians, police, and pharmaceutical executives. People who have never met you. People who do not know your name. People who will never face consequences for the decisions they make about your body.

Subject L did not consent to fentanyl. He bought what he thought were MDMA pills. He got fentanyl because prohibition removed every mechanism that would have told him what he was actually taking. In a regulated market — a pharmacy, a licensed dispensary, any system with basic quality control — those pills would have contained exactly what the label said. The dosage would have been printed on the packet. A pharmacist would have asked his age, checked his ID, and turned him away because he was fifteen.

Prohibition didn't protect Subject L. It stripped him of every protection that exists in every other consumer market on earth and then blamed him for the result.


The history is not what you think

The question most people never ask about drug laws is: why these drugs? Why is cannabis illegal and alcohol legal? Why is psilocybin Schedule 9 and Valium Schedule 4? Why is GHB — the only sleep aid on earth that actually preserves deep sleep — a criminal offence, while its chemically identical pharmaceutical version Xyrem costs $75,000 a year and is perfectly legal?

The answer is not pharmacology. It never was.

The Harrison Narcotics Tax Act of 1914 — the law that started it all — was not based on scientific evidence of harm. It was based on racism. Opium was associated with Chinese immigrants. Cocaine was associated with Black Americans. Marijuana was associated with Mexican labourers. The substances were criminalised not because they were dangerous but because the people using them were the wrong colour.

This is not a conspiracy theory. This is the documented legislative history. David Musto's The American Disease (1999) traces it line by line. The congressional testimony is on the record. Harry Anslinger, the first commissioner of the Federal Bureau of Narcotics, told Congress that marijuana made Black men look at white women. That is the foundation of modern drug law. That is what Subject L's life was destroyed by.

Nixon knew. His domestic policy advisor John Ehrlichman admitted it in a 1994 interview published by Harper's Magazine in 2016:

"The Nixon campaign in 1968, and the Nixon White House after that, had two enemies: the antiwar left and Black people. You understand what I'm saying? We knew we couldn't make it illegal to be either against the war or Black, but by getting the public to associate the hippies with marijuana and Blacks with heroin, and then criminalising both heavily, we could disrupt those communities. We could arrest their leaders, raid their homes, break up their meetings, and vilify them night after night on the evening news. Did we know we were lying about the drugs? Of course we did."

That is the war on drugs. Not public health. Not safety. Not protection. Social control dressed up as law enforcement. And the laws that came from it are still on the books. In Australia. In every state. Right now.


The safety paradox

The argument against legalisation always comes down to safety. "Drugs are dangerous." "People will die." "Think of the children."

Subject M has thought about the children. She thinks about one in particular. She thinks about him every time she drives past that flat in Baldivis.

Here is what the evidence says about safety:

Portugal decriminalised all drugs in 2001. Not legalised — decriminalised. Possession became a health matter, not a criminal one. In the 25 years since:

(EMCDDA data, 2001-2017. Not an opinion. Not a model. Twenty-five years of national population data.)

Switzerland introduced heroin-assisted treatment — actual medical-grade heroin, prescribed by doctors, administered in clinics. The results: 80 percent reduction in crime among participants. Dramatic improvements in health, housing stability, and employment. Zero overdose deaths in the programme. The programme has run for over two decades and is now permanent Swiss policy.

Canada legalised cannabis in 2018. Youth cannabis use remained stable or declined. The sky did not fall. The legal market displaced the black market. Quality control meant people knew what they were getting. Tax revenue funded public health.

The Netherlands has operated a cannabis tolerance policy for decades. Dutch youth use cannabis at lower rates than American youth. Lower rates. In the country where you can buy it in a shop.

Every single piece of evidence points the same direction. Regulation is safer than prohibition. Pharmacies are safer than car parks. Labels are safer than mystery powders. Pharmacists are safer than dealers.

The people who say "drugs are dangerous, therefore they must be illegal" have the logic exactly backwards. Drugs are dangerous, therefore they must be regulated. Illegality is the danger.


What Subject L would have got

Imagine a country that treated drug policy the way it treats alcohol, tobacco, and every other dangerous consumer product. Not a fantasy. Not a thought experiment. The systems already exist.

Subject L walks into a pharmacy. He is fifteen. The pharmacist asks for ID. He doesn't have it. He leaves. He tries again at seventeen. Same result. He comes back at eighteen with his driver's licence. The pharmacist checks it. He's eighteen. Legal.

The pharmacist gives him what he asked for. It is exactly what the label says it is. The dosage is printed on the packet. There is an information sheet inside that says what it does, how long it lasts, what not to mix it with, and what to do if something goes wrong. The pharmacist asks if he has any questions. There is a number on the packet for a free health line.

He takes it. It does what it's supposed to do. He wakes up the next day and goes to work.

That is what regulation looks like. That is what every other dangerous product in the country already has. Age verification. Ingredient labelling. Dosage information. Quality control. A point of contact if something goes wrong. We require this for paracetamol. We require it for cold and flu tablets. We require it for beer.

We do not require it for the substances that are most likely to kill you, because we made them illegal, and illegality removes all of it.


The pharmaceutical monopoly

There is one more thing Subject M needs you to know, and it is the thing that made her angriest.

GHB is a substance your body produces naturally. It occurs in your brain. It is the only known sleep aid that preserves and enhances slow-wave sleep — the deep sleep your brain needs for memory consolidation, cellular repair, immune function, and clearing the waste proteins associated with Alzheimer's disease. Every other sleep medication on the market — benzodiazepines, Z-drugs, antihistamines, melatonin at pharmacological doses — suppresses deep sleep. They knock you out, but they rob you of the sleep that actually heals.

GHB is Schedule I in Australia. Maximum penalty: 25 years.

Xyrem is the same molecule. Chemically identical. Same compound, same dose, same mechanism. Xyrem is Schedule III. Legal with a prescription. Costs between $50,000 and $75,000 a year.

The difference is not the molecule. The difference is the patent. GHB cannot be patented because it is a naturally occurring substance. Jazz Pharmaceuticals reformulated it as Xyrem, patented the formulation, and lobbied to keep GHB criminalised so that nobody could access the substance for pennies instead of paying $75,000 a year.

A substance your body makes. That uniquely preserves the sleep your brain needs. Criminalised so that a pharmaceutical company can charge seventy-five thousand dollars a year for the same thing.

When someone tells you drug laws exist to protect people, ask them: protect people from what? From a substance their own brain produces? Or from a price point that threatens a patent?


What Subject M wants

Subject M does not want drugs to be a free-for-all. She is not an anarchist. She is not a hippie. She is a dental nurse from Mandurah who watched her brother nearly die because the system that was supposed to protect him created the exact conditions that almost killed him.

She wants age verification. Pharmacies check ID. Dealers don't.

She wants quality control. Pharmacies label what's in the packet. Dealers don't know what's in the packet.

She wants dosage information. Pharmacies print it on the box. Dealers couldn't tell you if they wanted to.

She wants a health system that treats her brother like a patient, not a criminal. Portugal proved it works. Switzerland proved it works. Canada proved it works. The Netherlands proved it works. Every country that tried it got better outcomes than the countries that didn't.

She wants the people making these laws to answer one question: if prohibition works, why is it easier for a fifteen-year-old to buy pills in a car park than it is for him to buy a six-pack at BWS?

They won't answer it. They can't. Because the answer is that prohibition has never been about safety. It has been about control. Control of bodies. Control of communities. Control of markets. Control of who gets to decide what goes into your body and who profits from that decision.

Being your own man means deciding for yourself. It means nobody else — not a politician, not a police officer, not a pharmaceutical executive — gets to choose what enters your body. That is the most basic form of sovereignty there is. Everything else is just a matter of degree.

Subject L is twenty-two now. He's alive. Subject M still drives past that flat in Baldivis sometimes. She doesn't stop.

She wants you to know that the system didn't fail her brother. It worked exactly as designed. It removed every safeguard, every label, every age check, every quality control — and then it called the result a drug problem.

It's not a drug problem. It's a law problem. And the law is rape.


Sources

This is an opinion piece. The opinions are Subject M's. The evidence is not.

ClaimSource
Portugal: 80% reduction in overdose deaths (80 to 16)EMCDDA national data, 2001-2017
Portugal: HIV transmission 52% to 7%Portuguese national health data
Portugal: 60% increase in treatment uptakeEMCDDA monitoring reports
$1 trillion+ spent on US War on Drugs since 1971Drug Policy Alliance, 2023
100,000+ annual US overdose deathsCDC, 2023
Cannabis therapeutic index >1000:1, zero direct overdose deathsNutt et al. 2010; Lachenmeier & Rehm 2015
Alcohol therapeutic index ~10:1, 88,000 US deaths/yearCDC; NIAAA
Harrison Act driven by racial politicsMusto, The American Disease, 1999
Ehrlichman admissionBaum, Harper's Magazine, 2016
Netherlands: lower youth cannabis use than USEMCDDA, 2022
Switzerland HAT: 80%+ crime reduction, zero overdose deathsRehm et al. 2001
Canada: youth use stable/declining post-legalisationHealth Canada monitoring data
GHB uniquely preserves slow-wave sleepSleep medicine literature (multiple)
Xyrem: $50,000-75,000/year for same moleculeJazz Pharmaceuticals pricing
Drug scheduling not based on comparative riskNutt et al. 2010 (Lancet)
Drug supply increased despite $1T enforcementWerb et al. 2013
50-65% of incarceration drug-related (secondary effects)US Bureau of Justice Statistics, 2020